Brain Network Activation Analysis to Diagnose/Assess Treatment of Unipolar Major Depression and Bipolar I Depression (BNA-Mood)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01683214 |
Recruitment Status
:
Enrolling by invitation
First Posted
: September 11, 2012
Last Update Posted
: March 20, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Depression |
Study Type : | Observational |
Estimated Enrollment : | 250 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Potential Use of Brain Network Activation (BNA) Analysis Using Evoked Response Potentials to Diagnose Unipolar Major Depression and Bipolar I Depression and Assess Response to Treatment |
Study Start Date : | August 2012 |
Estimated Primary Completion Date : | March 2019 |
Estimated Study Completion Date : | December 2019 |

- Correlation of changes in BNA with changes in mood symptoms [ Time Frame: Beginning of study to end of study ]This is an observational study, so no other outcomes are measured

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Only subjects participating in another specific clinical trial will be invited to participate in this study.
The inclusion/exclusion criteria for this observational study are based on the individual inclusion/exclusion criteria for each of the studies and can be found for each of the studies on this website.
The specific studies and their numbers are found on their individual ClinicalTrials.gov site.
INCLUSION CRITERIA:
Bipolar I, depressed Major depression Meeting all criteria to sign the informed consent for each study included in this study who currently have a major depression (unipolar or bipolarI)
EXCLUSION CRITERIA:
Medically unstable (based on opinion of sponsor and PI Unable to meet the criteria to conform to the Rush University informed consent process

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01683214
Principal Investigator: | John M Zajecka, MD | RushUMC ; Rush University Medical center |
Responsible Party: | John Zajecka, Associate Professor of Psychiatry, Rush University Medical Center |
ClinicalTrials.gov Identifier: | NCT01683214 History of Changes |
Other Study ID Numbers: |
11122902 |
First Posted: | September 11, 2012 Key Record Dates |
Last Update Posted: | March 20, 2018 |
Last Verified: | March 2018 |
Additional relevant MeSH terms:
Depression Depressive Disorder Depressive Disorder, Major |
Behavioral Symptoms Mood Disorders Mental Disorders |